Genomic Therapy Matching in Rare and Refractory Cancers
Frank P. Lin(The University of Sydney), Emily Collignon(Australian Research Council), Sarah Chinchen(The University of Sydney), Katrin Marie Sjoquist(Australian Research Council), Craig Underhill(AstraZeneca (United Kingdom)), Lucille Sebastian(Heidelberg University), Benhur Amanuel(Edith Cowan University), Christine E. Napier(University of Sydney), Rosemary Harrup(University of Tasmania), Hayley P Barker(Australian Research Council), Peter Grimison(The University of Sydney), Damien Kee(Peter MacCallum Cancer Centre), Paul Leo(The University of Queensland), Anthony Glover(The University of Sydney), Hamish S. Scott(South Australia Pathology), Adrian Pokorny(Alice Springs Hospital), D. Thomas(Garvan Institute of Medical Research), Samantha R. Oakes(Allegheny College), Brett Hughes(Royal Brisbane and Women's Hospital), A. Mersiades(The University of Sydney), D. Nicolás Espinoza(The University of Texas at Austin), John P. Grady(Garvan Institute of Medical Research), James Blackburn(Garvan Institute of Medical Research), Subotheni Thavaneswaran(The University of Sydney), Mark Shackleton(Australian Research Council), Mandy L. Ballinger(Garvan Institute of Medical Research), Maya Kansara(Garvan Institute of Medical Research), Michail Charakidis(Royal Adelaide Hospital), Sagun Parakh(Australian Research Council), J. Simes(The University of Sydney), Geoffrey Peters(Australian Research Council), Adnan M. Nagrial(Australian Research Council), Maggie Moore(Australian Research Council), A. M. Joshua(Garvan Institute of Medical Research), Ken O’Byrne(Queensland University of Technology), D. Goldstein(UNSW Sydney), M. Zaheed(Garvan Institute of Medical Research), Stephen B. Fox(Peter MacCallum Cancer Centre), Michael Millward(The University of Western Australia), Steven Lane(Australian Research Council), Michael P. Brown(South Australia Pathology), Melissa Moore(Australian Research Council), David Ross(Australian Research Council), Australian Molecular Screening and Therapeutic program investigators and contributors, Chee Khoon Lee(The University of Sydney), Chris Karapetis(Australian Research Council), Jayesh Desai(Peter MacCallum Cancer Centre), Malinda Itchins(The University of Sydney), Mark J. Cowley(Australian Research Council), Paul Craft(Canberra Hospital)
Cited by 6
Related Papers
Whole–genome characterization of chemoresistant ovarian cancer
|Nature|2015|1.7k
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
|Nature Genetics|2012|1.2k
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
|New England Journal of Medicine|2012|1k